---
title: "Weekly Recap | Goldman Sachs -0.91%, most brokers rate it hold"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298791627.md"
description: "Goldman Sachs fell 0.91% this week to close at $1,029.18, underperforming the S&P 500 by roughly 0.11 percentage points. The week was choppy rather than directional: it opened at $1,040.55 on Tuesday, hit a high of $1,043.84, slid to $1,011.40 on Wednesday, then spent the rest of the week trading between $1,020 and $1,037 before settling at $1,029.18 on Friday. Weekly amplitude was 3.12%, and average daily volume of 1.50m shares came in about 15."
datetime: "2026-09-12T06:00:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298791627.md)
  - [en](https://longbridge.com/en/news/298791627.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298791627.md)
generator: "portal-rs"
---

# Weekly Recap | Goldman Sachs -0.91%, most brokers rate it hold

## The Week

Goldman Sachs fell 0.91% this week to close at $1,029.18, underperforming the S&P 500 by roughly 0.11 percentage points. The week was choppy rather than directional: it opened at $1,040.55 on Tuesday, hit a high of $1,043.84, slid to $1,011.40 on Wednesday, then spent the rest of the week trading between $1,020 and $1,037 before settling at $1,029.18 on Friday. Weekly amplitude was 3.12%, and average daily volume of 1.50m shares came in about 15.83% below the 60-day median, pointing to a relatively quiet tape.

## Key Events

Goldman was busy on multiple fronts this week. It arranged a $1bn at-the-market equity programme with Oklo, alongside BofA and Citi, and signed an equity distribution deal with Corning for up to $2bn in ATM issuance. In Europe, it kept adjusting voting stakes across Infineon, SBO, AUTO1, K+S, CECONOMY and Ubisoft, lifting its Ubisoft holding to 10.06%. On the people side, investment strategy chief Mossavar-Rahmani is set to retire, and two new co-heads were named for ISG. Goldman is also competing with BofA to manage IPO wealth for Anthropic employees, according to Bloomberg.

## Analyst Ratings

The stock is covered by 25 institutions: 6 rate it buy, 1 overweight, 16 hold, 1 underweight and 1 sell. The consensus rating is hold, with a consensus target of $1,141.65, about 10.93% above the current price of $1,029.18. Target prices range from $730 to $1,325, showing wide disagreement among brokers. Within the investment banking and brokerage industry, Goldman ranks 3rd out of 32 covered names.

## The Week Ahead

The coming week brings US retail sales, the Empire State manufacturing index and the NAHB housing market index. Retail sales are expected to rebound to 0.9% from a prior -0.6%, a print that could shift sentiment on financials. Goldman’s next earnings report is Q3 FY2026 on 13 October, with consensus estimates of $16.43 EPS and $17.7bn revenue. The Anthropic employee IPO wealth-management race may also keep Goldman in the headlines through subsequent sessions.

## In Short

The tension this week sits between a consensus target roughly 10.9% above spot and a strongly split rating distribution that leans neutral, while volume ran about 16% below its 60-day median and the latest session showed large-lot selling against small- and mid-sized buying. The next key test is the 13 October Q3 print, which should show whether revenue and profit expectations hold up, and whether the ATM mandates and Anthropic wealth-management push translate into core banking momentum.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [GS.US](https://longbridge.com/en/quote/GS.US.md)

## Related News & Research

- [Goldman Sachs trims K+S voting rights to 8.48% from 8.55%](https://longbridge.com/en/news/298876638.md)
- [Goldman Sachs lifts Aurubis voting rights to 9.12% from 7.3%](https://longbridge.com/en/news/299164083.md)
- [Want to invest in Anthropic before its IPO? Here's how.](https://longbridge.com/en/news/299139513.md)
- [Goldman Sachs trims Delivery Hero voting rights to 4.84% from 5%](https://longbridge.com/en/news/299168301.md)
- [Novo Nordisk, Anthropic Team Up For AI Drug Research](https://longbridge.com/en/news/299202341.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**